Detalhe da pesquisa
1.
Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527037
2.
Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice.
Eur J Immunol
; 46(12): 2719-2729, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27701733
3.
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.
J Immunol
; 191(5): 2514-2525, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904160
4.
Adjuvant solution for pandemic influenza vaccine production.
Proc Natl Acad Sci U S A
; 109(43): 17585-90, 2012 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23045649
5.
The importance of adjuvant formulation in the development of a tuberculosis vaccine.
J Immunol
; 188(5): 2189-97, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22291184
6.
Therapeutic immunization against Mycobacterium tuberculosis is an effective adjunct to antibiotic treatment.
J Infect Dis
; 207(8): 1242-52, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891286
7.
Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
Int J Infect Dis
; 130 Suppl 1: S47-S51, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36963657
8.
SARS-CoV-2 infection and immune responses.
AIMS Microbiol
; 9(2): 245-276, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37091818
9.
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis.
Vaccines (Basel)
; 11(1)2023 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679975
10.
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen.
Tuberculosis (Edinb)
; 138: 102302, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36586154
11.
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration.
Pharmaceuticals (Basel)
; 16(5)2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37242512
12.
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Infect Dis Ther
; 12(6): 1605-1624, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166567
13.
Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
AAPS PharmSciTech
; 13(2): 498-506, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22415641
14.
Mycobacterium abscessus: It's Complex.
Microorganisms
; 10(7)2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35889173
15.
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity.
Front Immunol
; 13: 840225, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35359957
16.
Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event.
Tuberculosis (Edinb)
; 137: 102272, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375278
17.
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations.
Front Microbiol
; 13: 935444, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36090093
18.
Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models.
Sci Rep
; 11(1): 9040, 2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33907221
19.
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
PLoS One
; 16(3): e0247990, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33705411
20.
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples.
bioRxiv
; 2021 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34230930